Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC Fines May Be More Useful To Advertising Opponents Than An FDA Ban

Executive Summary

Opponents of direct-to-consumer television ads will be better off with FDA having authority to fine companies for false and misleading television ads than they would have been if the agency was given the power to simply ban such ads, according to Scott Lassman, former Senior Assistant General Counsel at Pharmaceutical Research and Manufacturers of America
Advertisement

Related Content

Advertising Regulation Wiki? Industry Wants Authoritative But Frequently Updated FDA Guidance (And/Or Regs) On Internet Drug Promotion
Advertising Regulation Wiki? Industry Wants Authoritative But Frequently Updated FDA Guidance (And/Or Regs) On Internet Drug Promotion
FDA Begins Reviewing DTC Ads As User Fee Program Faces Pay Or Die Deadline
FDA’s DTC Pre-Review Authority Will Face Court Challenge, Lawyers Predict
FDA Study Of Rx TV Ads Should Recruit Participants More Broadly, Firms Say
DTC clock ticking
Rx TV Ads To Get FDA Study On How Visual Cues May Distract From Audio Risks
Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban
Risk Disclosure In Drug Ads Will Be FDA’s Focus After House Defeats DTC Ban
DTC Review Will Cost Industry $83,000 Per Ad Under FDA’s Final PDUFA Plan
Advertisement
UsernamePublicRestriction

Register

PS048837

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel